(Q34382549)

1 August 2017

title

Subgroup analyses in randomized controlled trials: the need for risk stratification in kidney transplantation (English)

1 reference

1 August 2017

main subject

kidney transplantation

1 reference

M Wagner

1

1 reference

1 August 2017

E M Balk

2

1 reference

1 August 2017

D M Kent

3

1 reference

1 August 2017

B L Kasiske

4

1 reference

1 August 2017

H Ekberg

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

American Journal of Transplantation

1 August 2017

published in

1 reference

1 August 2017

volume

9

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

2217-2222

1 reference

Design and analysis of clinical trials in transplantation: principles and pitfalls

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Why hasn't eliminating acute rejection improved graft survival?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Immunosuppressive drugs for kidney transplantation.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Interleukin 2 receptor antagonists for kidney transplant recipients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Strategies to improve long-term outcomes after renal transplantation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Subgroup analysis and other (mis)uses of baseline data in clinical trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Are randomized controlled trials sufficient evidence to guide clinical practice in type II (non-insulin-dependent) diabetes mellitus?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Can overall results of clinical trials be applied to all patients?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Multivariate analysis of risk factors in cadaver donor kidney transplantation.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

A consumer's guide to subgroup analyses

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

Increased impact of acute rejection on chronic allograft failure in recent era.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2997518

A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group

27 October 2018

1 reference

12 December 2020

A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATION

1 reference

12 December 2020

Baseline comorbidity in kidney transplant recipients: a comparison of comorbidity indices

1 reference

12 December 2020

Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial

1 reference

12 December 2020

An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase

1 reference

12 December 2020

The impact of human leukocyte antigen matching on transplant complications and immunosuppression dosage

1 reference

12 December 2020

10.1111/J.1600-6143.2009.02802.X

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference